Published in Drug Week, October 1st, 2004
A number of clinical sites located in Arizona and Southern California are expected to participate in this study with the possibility of increasing the number of sites elsewhere based upon disease outbreaks.
"This clinical trial has been designed to provide an additional demonstration of Avi-4020's safety and an opportunity to evaluate potential efficacy of our Neugene antisense drug against...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week